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ABSTRACT: Isoprenoids make up a remarkably diverse class of more than
25000 biomolecules that include familiar compounds such as cholesterol,
chlorophyll, vitamin A, ubiquinone, and natural rubber. The two essential
building blocks of all isoprenoids, isopentenyl pyrophosphate (IPP) and
dimethylallyl pyrophosphate (DMAPP), are ubiquitous in the three
domains of life. In most eukaryotes and archaea, IPP and DMAPP are
generated through the mevalonate pathway. We have identified two novel
enzymes, mevalonate-3-kinase and mevalonate-3-phosphate-5-kinase from
Thermoplasma acidophilum, which act sequentially in a putative alternate
mevalonate pathway. We propose that a yet unidentified ATP-independent
decarboxylase acts upon mevalonate 3,5-bisphosphate, yielding isopentenyl
phosphate, which is subsequently phosphorylated by the known
isopentenyl phosphate kinase from T. acidophilum to generate the universal
isoprenoid precursor, IPP.
Cholesterol, chlorophylls, hemes, ubiquinones, naturalrubbers, and archaeal membrane lipids are just a few
examples of more than 25000 biomolecules that make up the
diverse class of organic molecules called isoprenoids.1−3
Isoprenoids are found in all three domains of life and are
involved in essential processes such as electron transport, post-
translational modification, regulation of membrane fluidity, and
cytoskeleton assembly.4 All isoprenoids are composed of two or
more isoprene building blocks (five-atom branched hydro-
carbons) derived from isopentenyl pyrophosphate (IPP) and its
isomer, dimethylallyl pyrophosphate (DMAPP). Plants and
most eubacteria generate IPP and DMAPP from pyruvate and
glyceraldehyde 3-phosphate via the deoxyxylulose 5-phosphate
(DXP) pathway.5 Eukaryotes and archaea use a separate
pathway called the mevalonate pathway, which relies on acetyl-
CoA as the sole carbon source.6 The mevalonate pathway in
archaea is especially important because IPP and DMAPP are
used to make branched lipids that are connected to glycerol
through ether linkages to form membrane lipids.7 These
branched lipids and ether linkages are thought to promote
membrane stability at high temperatures.8,9
The canonical mevalonate pathway of eukaryotes can be
conceptually separated into two parts, which we term the upper
and lower stages (Figure 1). In the upper stage, three acetyl-
CoAs are condensed and reduced by NADPH to yield
mevalonate. In the lower stage, mevalonate is sequentially
phosphorylated to make mevalonate pyrophosphate and then
decarboxylated to yield IPP, which can be converted to
DMAPP by an isomerase.10 Recent phylogenetic analyses of
archaeal genomes identified strong homologues for the first
three enzymes in the pathway leading up to mevalonate.
However, in most cases, no homologues for phosphomevalo-
nate kinase or mevalonate pyrophosphate decarboxylase are
found.11 Furthermore, some archaea such as Thermoplasma,
Flavobacteria, and Gramella have no detectable mevalonate
kinase (MVK) homologues.11
While it has been hypothesized for more than a decade that
archaea possess an alternative mevalonate pathway based on
computational genomics,12 a complete pathway was not
elucidated until 2013 in the organisms Roseif lexus castenholzii13
and Haloferax volcanii.14 As shown by the blue arrows in Figure
1, instead of two phosphorylations followed by a decarbox-
ylation as seen in eukaryotes, some archaea phosphorylate once,
decarboxylate with mevalonate-5-phosphate decarboxylase, and
then phosphorylate again with isopentenyl phosphate kinase.
The end product is the same, IPP, but the enzymatic reactions
are distinct.
We were interested in obtaining thermophilic enzymes for in
vitro reconstruction of the mevalonate pathway.15 As part of
this effort, we targeted enzymes from an archeon, Thermo-
plasma acidophilum, which is naturally found in coal refuse piles
in the northeast United States, where it grows optimally at 59
°C.16 One of the target enzymes from T. acidophilum, encoded
by the ta1305 gene, was annotated as a mevalonate
pyrophosphate decarboxylase in GenBank [genes in italics
(e.g., ta1305) and their protein products capitalized in Roman
type (e.g., Ta1305)].17 Upon characterization of the expressed
enzyme, however, we discovered that it acts on mevalonate to
generate mevalonate 3-phosphate, a previously unknown
activity (see Figure 1). We were then able to identify a second
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novel kinase in T. acidophilum encoded by the ta0762 gene,
which phosphorylates mevalonate 3-phosphate to form
mevalonate 3,5-bisphosphate, another previously unknown
metabolite. We propose that these two new enzyme activities
are part of a novel mevalonate pathway utilized by T.
acidophilum (Figure 1).
■ MATERIALS AND METHODS
Materials. Miller LB medium (BD Difco) was used for
growth of bacterial strains. Escherichia coli BL21 Gold (DE3)
(Agilent) was used as the host strain for both cloning and
expression of recombinant proteins. Plasmid pET28a(+) was
purchased from Novagen. HotStart Taq Mastermix (Denville)
was used for gene amplification. Phusion DNA polymerase
(Finnzymes), Taq DNA ligase (MCLab), and T5 exonuclease
(Epicenter) were purchased separately and used to make the
assembly master mix (AMM) used for cloning. Ni-NTA resin
and miniprep reagents were purchased from Qiagen. Primers
were synthesized by ValueGene. All other chemicals were
purchased from Sigma-Aldrich unless otherwise noted.
Cloning. Genes were amplified by polymerase chain
reaction (PCR) from T. acidophilum genomic DNA (ATCC
catalog no. 25905D). A modified Gibson method was used to
assemble all constructs.18 Primers included 15−20 bp
complementary to the ends of the target gene and 15−20 bp
complementary to the NdeI and XhoI insertion sites of
pET28a(+), which allowed for the addition of an N-terminal
six-His tag. Ten nanograms of pET28a(+) digested with NdeI
and XhoI was mixed with 30 ng of PCR product and 7 μL of
assembly mix [0.1 M Tris-HCl (pH 7.5), 0.2 mM dNTPs, 1
Figure 1. Mevalonate pathways. Eukaryotes use the left side of the fork after mevalonate 5-phosphate (black), and archaea use the right side (blue).
The two enzymes identified in this study suggest an alternative pathway branching from mevalonate (red). A predicted decarboxylase (bold arrow)
connects mevalonate 3,5-bisphosphate to isopentenyl phosphate.
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mM NAD+, 5% PEG 8K, 10 mM DTT, 10 mM MgCl2, 0.00375
unit/μL T5 exonuclease, 0.012 μL Phusion DNA polymerase,
and 4 units/μL TaqDNA ligase]. After incubation at 50 °C for
2 h, 5 μL was then used to transform BL21 Gold (DE3), and
transformants were selected by being plated on LB agar
containing 50 μg/mL kanamycin.
Expression and Purification. All E. coli strains were grown
at 37 °C in LB medium with 50 μg/mL kanamycin. One liter of
LB medium was inoculated with 5 mL of overnight starter
culture. Protein expression was induced during the log phase
(OD600 of 0.5−0.8) with 0.5 mM IPTG. After 20 h, cells were
pelleted, resuspended in 12 mL of buffer A [50 mM Tris-HCl
(pH 7.5) and 100 mM NaCl], and lysed by sonication, and cell
debris was removed by centrifugation at 30000g for 20 min.
The lysate was mixed with 3 mL of a Ni-NTA slurry and
incubated at 4 °C while being gently mixed. After 1 h, the lysate
mixture was applied to a column and the Ni-NTA beads were
washed three times with 25 mL of buffer A containing 10 mM
imidazole. Protein was then eluted with 4 mL of buffer A
containing 250 mM imidazole. For kinetic characterization,
enzymes were further purified on an AKTA FPLC system using
a Superdex S200 10/300 GL gel filtration column run with
buffer A, at a rate of 0.5 mL/min.
Enzyme Assays. Enzymes were assayed for the ability to
hydrolyze ATP to ADP by coupling the reactions to pyruvate
kinase (PK) and lactate dehydrogenase (LDH) from rabbit
muscle.19 Assays were conducted in duplicate using a 200 μL
volume at 55 °C and contained 1 mM ATP, 10 mM KCl, 5 mM
MgCl2, 5 mM 2-mercaptoethanol, 1 mM PEP, 0.5 mM NADH,
1.4 μg of enzyme, 1.0 μL of LDH/PK mix (Sigma), and 50 mM
bis-tris propane (pH 8.5). The pH of all buffers was adjusted at
25 °C. All reagents were incubated for 10 min at the desired
temperature, and then substrate was added to a final
concentration of 1 mM. The absorbance at 340 nm was
recorded over 20 min on a Spectramax M5 microplate reader.
Assays for activity with mevalonate 3-phosphate were
conducted in a sequential manner using 0.5 mM mevalonate,
3 mM PEP, and 0.75 mM NADH. The second enzyme was
added after complete conversion of mevalonate to mevalonate
3-phosphate as monitored on the microplate reader. All assay
conditions included a control with direct addition of 1 mM
ADP to ensure PK and LDH activities were not rate-limiting.
Free Phosphate Assays. Phosphate assays were conducted
in a 96-well plate using reagents from a glycosyltransferase
activity kit (R&D Systems).20 Two microliters of an enzyme
reaction mixture was combined with 48 μL of doubly distilled
water (ddH2O), followed by 30 μL of malachite green reagent
A, 100 μL of ddH2O, and 30 μL of malachite green reagent B.
After a 20 min incubation, the absorbance at 620 nm was
measured on a Spectramax M5 microplate reader alongside five
standards of 0.0−1.0 mM KH2PO4 prepared identically.
Mevalonate pyrophosphate decarboxylase from Saccharomyces
cerevisiae, prepared as described previously,15 served as a
positive control for the release of free phosphate through the
decarboxylation of (RS)-mevalonate pyrophosphate.
Gas Chromatography. Isoprenol was extracted from 200
μL of an enzymatic reaction mixture with 600 μL of hexanes.
Two microliters of the hexane layer was injected into the GC-
FID (HP5890II) instrument equipped with an HP-INNOWAX
column (0.320 mm × 30 m, Agilent). The carrier gas was
helium with a flow rate of 5 mL/min. The oven temperature
was kept at 50 °C for 2 min, increased to 100 °C at a rate of 10
°C/min, increased to 250 °C at a rate of 25 °C/min, and finally
held at 250 °C for 2 min. The inlet and detector temperatures
were kept at 250 and 330 °C, respectively. The isoprenol
concentration was determined by comparison to authentic
standards.
Product Identification by NMR. Enzymatic reactions for
NMR were conducted in a 250 μL volume using 1.4 μg of
enzyme, 20 mM (R)-mevalonate, 20 mM PEP, 1 mM ATP, 1
mM MgCl2, and 10 μL of LDH/PK enzyme mix (Sigma),
which was diluted and reconcentrated to remove glycerol. The
pH was adjusted to 7.5 at 25 °C using 1.0 M KOH with 20 mM
PEP serving as a phosphate buffer in addition to being a
substrate for pyruvate kinase. The reaction mixtures were
incubated for 6 h at 42 °C. The completed 250 μL reaction
mixture was diluted to 500 μL with 99.9% D2O from
Cambridge Isotope Laboratories and aliquoted into an NMR
tube. All spectra were acquired at ambient temperature on a
500 MHz Bruker AV500 spectrometer equipped with a
cryoprobe. Data were processed using Topspin version 3.1.
For the spectra of mevalonate 3,5-bisphosphate, the PEP
concentration in the enzymatic reaction mixture was doubled to
40 mM to allow for full conversion of 20 mM (R)-mevalonate
to mevalonate 3,5-bisphosphate.
Product Identification by ESI Mass Spectrometry.
Negative ion electrospray mass spectrometry data were
collected with a Waters LCT Premier XE time-of-flight
instrument controlled by MassLynx version 4.1. Samples from
the NMR tubes were transferred to GC vials and injected into
the multimode ionization source with a Waters Acquity UPLC
system. The flow injection solvent was a 50/50 MeOH/MeCN
mixture (LCMS grade, VWR Scientific), and water blanks were
run between all samples. The lock mass standard for accurate
mass determination was leucine enkephalin (Sigma catalog no.
L9133).
Biochemical Characterization. The optimal pH for the
enzymes was determined by kinase assays in 0.5 pH unit
increments ranging from pH 6.5 to 9.5 using 50 mM bis-tris
propane. The optimal temperature of the enzymatic assay was
determined in 5 °C increments ranging from 25 to 60 °C. We
were unable to obtain direct kinetic measurements above 60 °C
because it is the maximal temperature of the Spectramax M5
microplate reader. To complement this data, the temperature
stability was assayed by incubating 30 μL of 0.170 mg/mL
Ta1305 or 0.067 mg/mL Ta0762 for 1 h at 30−90 °C in 4−6
°C increments using a thermocycler gradient (Eppendorf ProS
PCR machine). Kinetic measurements for Ta1305 were taken
at pH 8.5 and 55 °C with 1.4 μg of enzyme over a range of
0.03−4.00 mM (R)-mevalonate. Ta0762 kinetic measurements
were performed at pH 8.0 and 60 °C with 0.5 μg of enzyme
over the range of 0.03−1.00 mM mevalonate 3-phosphate
(produced enzymatically). kcat values were not corrected for
temperature because the temperature of each experiment is
indicated.
■ RESULTS
Ta1305 Is Active on Mevalonate. Three genes from T.
acidophilum annotated as mevalonate pyrophosphate decarbox-
ylases in GenBank,17 ta1305, ta0893, and ta0461, were cloned
and expressed in E. coli. Known mevalonate pyrophosophate
decarboxylases hydrolyze ATP to ADP as part of their
mechanism21 and can therefore be conveniently studied using
standard kinase assays.19 No activity was detected in a kinase
assay using the expected substrate, 1 mM (RS)-mevalonate
pyrophosphate. We therefore retested the three enzymes with
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mevalonate and mevalonate 5-phosphate. To our surprise,
Ta1305 showed significant ATP consumption in the presence
of 1 mM (RS)-mevalonate (Figure 2). No activity was detected
with any other substrate or enzyme combination.
Ta1305 Is Not a Mevalonate-5-kinase. The only known
enzyme to act on mevalonate is mevalonate-5-kinase, which
phosphorylates the 5-OH group. We therefore tested if Ta1305
was a mevalonate-5-kinase using a sequential assay. Mevalonate
and ATP were incubated with Ta1305, followed by addition of
phosphomevalonate kinase (PMVK), which consumes ATP in
the presence of mevalonate 5-phosphate. No activity was
detected upon addition of PMVK. When we replaced Ta1305
with an authentic mevalonate-5-kinase from S. cerevisiae,
however, robust activity was observed. Thus, Ta1305 is not a
mevalonate-5-kinase.
Ta1305 Shows No Decarboxylase Activity As Sug-
gested by Homology. The fact that Ta1305 is 18% identical
with mevalonate pyrophosphate decarboxylase from S.
cerevisiae22 yet acts on mevalonate suggests that it might
directly decarboxylate mevalonate. The expected product of
mevalonate decarboxylation would be 3-methylbut-3-en-1-ol
(isoprenol) instead of isopentenyl pyrophosphate. To test this
hypothesis, we allowed the reaction to go to completion from
1.0 mM mevalonate and analyzed the mixture for any isoprenol
production by extracting with hexane followed by gas
chromatography. No isoprenol was detected, even after
allowing the reaction mixture to incubate for 48 h at 37 °C
to promote spontaneous decarboxylation. Positive controls
made by spiking the enzymatic reaction mixture with authentic
isoprenol indicated that we would have detected isoprenol
production as low as 0.01 mM.
Ta1305 Is a Kinase. While the Ta1305 enzyme consumed
ATP in the presence of mevalonate, the fate of the phosphate
remained unclear. To confirm that this enzyme does not
decarboxylate mevalonate and release free phosphate, we
assayed the reaction mixture for free phosphate after
completion of the reaction using 1 mM ATP and 1 mM
(RS)-mevalonate.20 We found no detectable free phosphate,
suggesting that the substrate is phosphorylated. The same
experiment utilizing authentic mevalonate pyrophosphate
decarboxylase from S. cerevisiae as a positive control and its
substrate, (RS)-mevalonate pyrophosphate, yielded 0.57 mM
free phosphate as expected for the racemic substrate mixture.
Phosphorylation of mevalonate was further verified by ESI
mass spectrometry. High-resolution negative ion electrospray
ionization mass spectra of the reaction products were recorded.
We observed a mass of m/z 227.0313, which is within m/z
0.00008 of the mass expected for a phosphorylated mevalonate
[C6H13O7P − H]− (Figure S1 of the Supporting Information).
These results suggest that Ta1305 phosphorylates mevalonate
in an ATP-dependent manner.
Ta1305 Generates Mevalonate 3-Phosphate. The
results so far indicate that Ta1305 is a mevalonate kinase, but
there are three potential sites of phosphorylation on
mevalonate: the 3-OH group, 5-OH group, and the carboxylate.
To identify the site of phosphorylation, we used 13C NMR.
While mevalonate alone produces six single peaks in its 13C
NMR spectrum, coupling of the carbons to a phosphate will
generate doublets for any carbon within three bonds of a 31P
atom.23 The three possible phosphorylated products of Ta1305
would each generate a unique set of doublets, which allows for
positive identification of the phosphorylated species.
To prepare samples for natural abundance NMR analysis, we
wanted to keep the ATP concentrations low to simplify the
NMR spectra. We therefore regenerated ATP in situ from PEP
using pyruvate kinase. In this manner, ATP is kept at a very low
concentration and recycled, leaving only contributions from the
much simpler spectrum of PEP. A spectrum of the no enzyme
control sample [i.e., 10 mM (R)-mevalonate] showed six singlet
peaks as expected (Figure 3A), and the carbons were assigned
with the guidance of computationally predicted spectra from
the Human Metabolome Database24 and ChemNMR Pro
version 13.0.25 Another control sample employing yeast
mevalonate-5-kinase showed splitting at carbons 4 and 5 as
expected for mevalonate 5-phosphate (Figure 3B). The product
of Ta1305 activity, however, showed splitting at carbons 2−4
and 6, which is consistent with phosphorylation at the 3-OH
position (Figure 3C). Thus, we can annotate Ta1305 as
mevolonate-3-kinase (full 13C NMR spectra are available as
Figures S2−S4 of the Supporting Information).
Identification of an Enzyme That Acts on Mevalonate
3-Phosphate. To identify the next step in a possible new
mevalonate pathway, we screened enzymes that might further
phosphorylate the newly identified metabolite, mevalonate 3-
phosphate. Seven genes annotated in GenBank as kinases from
T. acidophilum were cloned, and the proteins were expressed
and purified. We chose two putative kinase genes found near
ta1305 in the genome (ta1304 and ta1307), three genes that
were homologous to those of the mevalonate kinase family
(ta0344, ta0436, and ta0546), and two additional genes that
were annotated as small molecule kinases (ta0762 and ta0364)
but, to the best of our knowledge, had not been characterized.
We screened the putative kinases for their ability to
phosphorylate mevalonate 3-phosphate using a sequential
kinase assay. We first used Ta1305 to generate mevalonate 3-
phosphate from mevalonate in situ (monitored by ADP
production). After the reaction had reached completion, we
added the second test enzyme. Of the seven enzymes tested,
only Ta0762 showed activity with mevalonate 3-phosphate
Figure 2. Enzyme specificity. The enzymes were incubated with the
following substrates each at 1.0 mM: mevalonate (MVA), mevalonate
5-phosphate (M5P), mevalonate 5-pyrophosphate (MPP), mevalonate
3-phosphate (M3P), and 2-phosphoglycerate (2PG). A no enzyme
control (NE) was also performed. ATP (1.0 mM) was included, and
ADP production was monitored at 55 °C and pH 8.5 for Ta1305 and
60 °C and pH 8.0 for Ta0762.
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(Figure 2). No activity was detected with mevalonate,
mevalonate 5-phosphate, or mevalonate pyrophosphate.
Ta0762 had been computationally annotated as 2-phosphogly-
cerate kinase, though no activity was detected with 2-
phosphoglycerate (Figure 2). This result suggests Ta0762 is
misannotated and acts in a pathway directly after mevalonate-3-
kinase. To determine if Ta0762 is a kinase, we conducted a free
phosphate assay with 2.0 mM ATP and 1.0 mM mevalonate in
a sequential enzymatic reaction. After monitoring the reaction
until it reached completion on the microplate reader, we
detected only 0.02 mM free phosphate, suggesting mevalonate
3-phosphate is also phosphorylated. To confirm the production
of a doubly phosphorylated product, we again employed ESI
mass spectrometry. The reaction product had a mass of m/z
307.0016, which is within m/z 0.0031 of the mass expected for
mevalonate diphosphate [C6H14O10P2 − H]− (Figure S5 of the
Supporting Information).
Ta0762 Generates Mevalonate 3,5-Bisphosphate. 13C
NMR was employed to determine the position of phosphor-
ylation by Ta0762 using the same procedure used to identify
mevalonate 3-phosphate. Splitting was observed at carbons 2−
6, which is consistent with phosphates attached to the 3-OH
and 5-OH positions simultaneously (Figure 3D, full spectrum
in Figure S6 of the Supporting Information). In addition,
carbon 4 showed a doublet of doublets pattern consistent with
contributions from 31P atoms bonded in both the 3-OH and 5-
OH positions simultaneously. The observed spectrum is
consistent with the structure of mevalonate 3,5-bisphosphate.
Biochemical Characterization of Mevalonate-3-kinase
and Mevalonate-3-phosphate-5-kinase. To characterize
the kinetic parameters of the new enzymes, we first determined
the optimal pH and temperature for each enzyme. As shown in
Figure 4, mevalonate-3-kinase performs optimally at pH 8.5 and
55 °C. Mevalonate-3-phosphate-5-kinase performs optimally at
60 °C but does not demonstrate significant pH dependence in
the pH range of 6.5−9.0. Both enzymes are quite stable,
retaining more than 95% of their activity after incubation at 60
°C for 1 h. Under optimal conditions with (R)-mevalonate as a
substrate, mevalonate-3-kinase was found to have a Km of 97 ±
6 μM and a kcat of 5.0 ± 0.1 s
−1 (Figure S7 of the Supporting
Information), which are comparable to those of mevalonate-5-
kinase from the archeon Methanosarcina mazei (Km of 68 ± 4
μM and kcat of 4.3 ± 0.2 s
−1).26 Mevalonate-3-phosphate-5-
kinase is significantly faster with a kcat of approximately 9.0 s
−1.
We were unable to accurately determine the Km for
mevalonate-3-phosphate-5-kinase, however, because the sub-
strate is not commercially available and the detection limit of
our assay is 30 μM substrate. Nevertheless, the enzyme was still
at Vmax when it was assayed with 60 μM mevalonate 3-
phosphate, indicating that the Km is well below 60 μM. For
both enzymes, ATP was confirmed to be at saturation because
for both enzymes, increasing the ATP concentration from 1 to
5 mM saw no change in the observed rates.
■ DISCUSSION
We propose the two enzymes described here constitute part of
a novel mevalonate pathway in T. acidophilum that splits at
mevalonate and rejoins the known archaeal mevalonate
pathway at isopentenyl phosphate (Figure 1, red arrows). In
T. acidophilum, there is strong evidence of the presence of
acetoacetyl-CoA thiolase, HMG-CoA synthase, HMG-CoA
reductase, isopentenyl phosphate kinase, and isopentenyl
pyrophosphate isomerase based on homology10 and experi-
ment.27,28 However, no homologues have been identified for
mevalonate-5-kinase or phosphomevalonate kinase in this
organism. Most surprising is the absence of mevalonate-5-
kinase because it is the only enzyme previously known to act on
mevalonate. We propose that T. acidophilum contains a novel
pathway in which mevalonate-3-kinase phosphorylates meval-
onate at the 3-OH position, followed by mevalonate-3-
phosphate-5-kinase, which phosphorylates the 5-OH position,
and finally an unidentified decarboxylase converts mevalonate
3,5-bisphosphate to isopentenyl phosphate (Figure 1, red
arrows).
The proposed decarboxylase enzyme would conduct the
same chemical transformation as mevalonate pyrophosphate
decarboxylase but in an ATP-independent manner because the
substrate is already phosphorylated in the correct position for
decarboxylation. We tested apparent mevalonate pyrophos-
phate decarboxylase homologues Ta0461 and Ta0893 for
activity on mevalonate 3,5-bisphosphate, but none was detected
in our hands. Both enzymes expressed to inclusion bodies, and
after many attempts, we were unable to refold these proteins in
high yield; therefore, it remains possible that one of them is the
missing decarboxylase. We also considered the possibility of an
alternative pathway in which IP kinase acts directly on
mevalonate 3,5-bisphosphate. When we incubated mevalonate
3,5-bisphosphate with IP kinase, however, we saw no release of
Figure 3. 13C NMR of completed enzymatic reactions (10 mM
products) in 50% D2O. The chemical shifts of the six mevalonate
carbons are listed along with the J couplings from 31P (red): (A) no
enzyme, (B) yeast mevalonate-5-kinase, (C) Ta1305 activity, and (D)
Ta1305 and Ta0762 activity. Reactions were monitored to >96%
completion before spectra were acquired. Full spectra are shown in
Figures S2−S4 and S6 of the Supporting Information.
aA doublet of doublets was seen at a JC4−P1 of 7.1 and a JC4−P2 of 4.4.
All other splittings are simple doublets.
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phosphate (decarboxylation) or ATP consumption (kinase
activity).
The observation of stable tertiary phosphorylated mevalonate
is striking because the mechanism of mevalonate pyrophos-
phate decarboxylase is thought to proceed through a transient
tertiary phosphorylated intermediate.29,30 In a previous
mechanistic study of mevalonate pyrophosphate decarboxylase,
a heavy oxygen atom was incorporated into mevalonate
pyrophosphate at the 3-OH position, and then after ATP-
dependent conversion to IPP, the heavy oxygen was detected in
free phosphate.29 This suggests a simple mechanism in which
the γ-phosphate from ATP is transferred to the 3-OH position
of mevalonate pyrophosphate, activating the substrate for
decarboxylation. The current literature predicts this tertiary
phosphorylated molecule is inherently unstable and falls apart
with concomitant decarboxylation.31,32 Our observation of
mevalonate 3-phosphate and mevalonate 3,5-bisphosphate as
stable metabolites at 55 °C suggests that the decarboxylation
step requires enzyme catalysis, however.
To shed light on the reason why mevalonate-3-kinase does
not function as a decarboxylase, the active site residues of five
bacterial mevalonate pyrophosphate decarboxylases (MDCs)
were aligned with mevalonate-3-kinase from T. acidophilum. We
focused on nine active site residues shown to interact with
mevalonate pyrophosphate in a MDC crystal structure by Barta
et al.32 Only four of nine highly conserved residues are
preserved in mevalonate-3-kinase (Figure S8 of the Supporting
Information). It is likely that these five nonconserved residues
(L19, L20, I23, D190, and T276) contribute to the loss of
decarboxylase activity.
Because of the apparently low reliability of predicting
function through sequence homology, we cannot tell which
organisms have a true copy of mevalonate-3-kinase and which
have the classical mevalonate pyrophosphate decarboxylase.
Sequence homology obtained through a protein BLAST
search34 revealed five homologues of mevalonate-3-kinase that
were >30% identical. All five are annotated as “mevalonate
pyrophosphate decarboxylase” or “hypothetical protein” and
belong to the order Thermoplasmatates: Thermoplasma
volcanium (67%), Thermoplasmatales archeon (54%), Ferroplas-
ma sp. Type II (45%), Ferroplasma acidarmanus (42%), and
Picrophilus torridus (39%). For comparison, the level of
Figure 4. Biochemical characterization of mevalonate-3-kinase (A−C) and mevalonate-3-phosphate-5-kinase (D−F). (A) Activity at pH 8.5 over a
temperature range of 25−60 °C in 5 °C increments. (B) Residual activity after the sample had been incubated at the indicated temperature for 1 h
and then assayed at 55 °C and pH 8.5. (C) Activity at 25 °C over a pH range of 6.5−9.5 in pH increments of 0.5. (D) Activity at pH 8.0 over a
temperature range of 25−60 °C in 5 °C increments. (E) Residual activity after the sample had been incubated at the indicated temperature for 1 h
and then assayed at 60 °C and pH 8.0. (F) Activity at 60 °C over a pH range of 6.5−9.5 in pH increments of 0.5. Curve fits in panels A−F were
generated by a Stineman function33 and included simply to highlight data trends.
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sequence identity between mevalonate-3-kinase and classical
yeast MDC is 19%.
Taken together, we have identified two novel enzymes,
mevalonate-3-kinase and mevalonate-3-phosphate-5-kinase,
which act sequentially in a putative alternate mevalonate
pathway in T. acidophilum. Full confirmation of this pathway
requires identification of a missing mevalonate 3,5-bisphos-
phate decarboxylase. Our findings raise important questions
about the mechanism of mevalonate pyrophosphate decarbox-
ylases because tertiary phosphorylated mevalonate species
clearly exist as stable metabolites.
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